Discontinued — last reported Q4 '25
DexCom Other Financing remained flat by 0.0% to -$1.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.8%, from -$1.70M to -$1.90M. Over 4 years (FY 2021 to FY 2025), Other Financing shows an upward trend with a -8.3% CAGR.
An increase in cash outflows here may indicate non-recurring costs related to financing arrangements or adjustments to minority interests, while inflows might represent capital contributions or other unique financing events.
This metric represents the net cash flows resulting from financing transactions that do not fall into standard categorie...
Most large-cap companies report this as a catch-all line in the financing section; peers often include items like debt issuance costs or minor equity-related adjustments here.
other_financing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$400.00K | -$800.00K | -$800.00K | -$4.80M | -$4.30M | -$7.20M | -$1.00M | -$1.10M | -$1.10M | -$1.20M | $4.90M | -$8.70M | -$1.40M | -$1.30M | -$1.60M | -$1.70M | -$1.70M | -$1.70M | -$1.90M | -$1.90M |
| QoQ Change | — | -100.0% | +0.0% | -500.0% | +10.4% | -67.4% | +86.1% | -10.0% | +0.0% | -9.1% | +508.3% | -277.6% | +83.9% | +7.1% | -23.1% | -6.3% | +0.0% | +0.0% | -11.8% | +0.0% |
| YoY Change | — | — | — | — | -975.0% | -800.0% | -25.0% | +77.1% | +74.4% | +83.3% | +590.0% | -690.9% | -27.3% | -8.3% | -132.7% | +80.5% | -21.4% | -30.8% | -18.8% | -11.8% |